Also
- Share via
Biogen Idec Inc., which withdrew multiple sclerosis drug Tysabri in February, said it would cut about 650 jobs, or 17% of its workforce, and divest its drug Amevive for the skin condition psoriasis.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
